List of Tables
Table 1. Global Eltrombopag Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Eltrombopag Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Eltrombopag Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Eltrombopag Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Eltrombopag Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Eltrombopag Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Eltrombopag Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Eltrombopag Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Eltrombopag Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Eltrombopag Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Eltrombopag Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Eltrombopag Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Eltrombopag Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Eltrombopag Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Eltrombopag Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Eltrombopag Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Eltrombopag Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Eltrombopag Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Eltrombopag Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Eltrombopag Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Eltrombopag Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Eltrombopag Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Eltrombopag Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Eltrombopag Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Eltrombopag Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Eltrombopag Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Eltrombopag Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Eltrombopag Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Eltrombopag Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Eltrombopag Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Eltrombopag Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Eltrombopag Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Eltrombopag Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Eltrombopag Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Eltrombopag Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Eltrombopag Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Eltrombopag Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Eltrombopag Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Eltrombopag Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Eltrombopag Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Eltrombopag Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Eltrombopag Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Eltrombopag Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Eltrombopag Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Eltrombopag Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Eltrombopag Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Eltrombopag Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Eltrombopag Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Eltrombopag Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Eltrombopag Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Eltrombopag Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Eltrombopag Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Eltrombopag Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Eltrombopag Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Eltrombopag Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Eltrombopag Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Eltrombopag Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Eltrombopag Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Eltrombopag Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Eltrombopag Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Eltrombopag Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Eltrombopag Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Eltrombopag Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Eltrombopag Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Eltrombopag Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Eltrombopag Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Eltrombopag Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Eltrombopag Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Eltrombopag Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novartis Eltrombopag Drugs Product
Table 74. Novartis Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva Eltrombopag Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Teva Eltrombopag Drugs Product
Table 79. Teva Recent Developments/Updates
Table 80. Annora Pharma Company Information
Table 81. Annora Pharma Description and Business Overview
Table 82. Annora Pharma Eltrombopag Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Annora Pharma Eltrombopag Drugs Product
Table 84. Annora Pharma Recent Developments/Updates
Table 85. Hetero Company Information
Table 86. Hetero Description and Business Overview
Table 87. Hetero Eltrombopag Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Hetero Eltrombopag Drugs Product
Table 89. Hetero Recent Developments/Updates
Table 90. Actavis Laboratories Company Information
Table 91. Actavis Laboratories Description and Business Overview
Table 92. Actavis Laboratories Eltrombopag Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Actavis Laboratories Eltrombopag Drugs Product
Table 94. Actavis Laboratories Recent Developments/Updates
Table 95. Amneal Pharmaceuticals Company Information
Table 96. Amneal Pharmaceuticals Description and Business Overview
Table 97. Amneal Pharmaceuticals Eltrombopag Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Amneal Pharmaceuticals Eltrombopag Drugs Product
Table 99. Amneal Pharmaceuticals Recent Developments/Updates
Table 100. Sichuan Kelun Pharmaceutical Company Information
Table 101. Sichuan Kelun Pharmaceutical Description and Business Overview
Table 102. Sichuan Kelun Pharmaceutical Eltrombopag Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sichuan Kelun Pharmaceutical Eltrombopag Drugs Product
Table 104. Sichuan Kelun Pharmaceutical Recent Developments/Updates
Table 105. Qilu Pharmaceutical Company Information
Table 106. Qilu Pharmaceutical Description and Business Overview
Table 107. Qilu Pharmaceutical Eltrombopag Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Qilu Pharmaceutical Eltrombopag Drugs Product
Table 109. Qilu Pharmaceutical Recent Developments/Updates
Table 110. Grand Pharmaceutical Company Information
Table 111. Grand Pharmaceutical Description and Business Overview
Table 112. Grand Pharmaceutical Eltrombopag Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Grand Pharmaceutical Eltrombopag Drugs Product
Table 114. Grand Pharmaceutical Recent Developments/Updates
Table 115. Zhejiang Hisun Pharmaceutical Company Information
Table 116. Zhejiang Hisun Pharmaceutical Description and Business Overview
Table 117. Zhejiang Hisun Pharmaceutical Eltrombopag Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Zhejiang Hisun Pharmaceutical Eltrombopag Drugs Product
Table 119. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 120. Chia Tai Tianqing Pharmaceutical Company Information
Table 121. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 122. Chia Tai Tianqing Pharmaceutical Eltrombopag Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Chia Tai Tianqing Pharmaceutical Eltrombopag Drugs Product
Table 124. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 125. Changzhou Pharmaceutical Factory Company Information
Table 126. Changzhou Pharmaceutical Factory Description and Business Overview
Table 127. Changzhou Pharmaceutical Factory Eltrombopag Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Changzhou Pharmaceutical Factory Eltrombopag Drugs Product
Table 129. Changzhou Pharmaceutical Factory Recent Developments/Updates
Table 130. Shandong Jewim Pharmaceutical Company Information
Table 131. Shandong Jewim Pharmaceutical Description and Business Overview
Table 132. Shandong Jewim Pharmaceutical Eltrombopag Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Shandong Jewim Pharmaceutical Eltrombopag Drugs Product
Table 134. Shandong Jewim Pharmaceutical Recent Developments/Updates
Table 135. Guangdong Longfu Pharmaceutical Company Information
Table 136. Guangdong Longfu Pharmaceutical Description and Business Overview
Table 137. Guangdong Longfu Pharmaceutical Eltrombopag Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Guangdong Longfu Pharmaceutical Eltrombopag Drugs Product
Table 139. Guangdong Longfu Pharmaceutical Recent Developments/Updates
Table 140. Ningbo Menovo Tiankang Pharmaceutical Company Information
Table 141. Ningbo Menovo Tiankang Pharmaceutical Description and Business Overview
Table 142. Ningbo Menovo Tiankang Pharmaceutical Eltrombopag Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Ningbo Menovo Tiankang Pharmaceutical Eltrombopag Drugs Product
Table 144. Ningbo Menovo Tiankang Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Eltrombopag Drugs Distributors List
Table 148. Eltrombopag Drugs Customers List
Table 149. Eltrombopag Drugs Market Trends
Table 150. Eltrombopag Drugs Market Drivers
Table 151. Eltrombopag Drugs Market Challenges
Table 152. Eltrombopag Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Eltrombopag Drugs
Figure 2. Global Eltrombopag Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Eltrombopag Drugs Market Share by Type: 2025 & 2032
Figure 4. Tablets Product Picture
Figure 5. Oral Suspension Product Picture
Figure 6. Global Eltrombopag Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Eltrombopag Drugs Market Share by Application: 2025 & 2032
Figure 8. Hospital and Clinic
Figure 9. Pharmacy
Figure 10. Other
Figure 11. Global Eltrombopag Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Eltrombopag Drugs Market Size (US$ Million), 2021–2032
Figure 13. Global Eltrombopag Drugs Sales (K Units), 2021–2032
Figure 14. Global Eltrombopag Drugs Average Price (US$/Unit), 2021–2032
Figure 15. Eltrombopag Drugs Report Years Considered
Figure 16. Eltrombopag Drugs Sales Share by Manufacturers in 2025
Figure 17. Global Eltrombopag Drugs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Eltrombopag Drugs Players: Market Share by Revenue in Eltrombopag Drugs in 2025
Figure 19. Eltrombopag Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Eltrombopag Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Eltrombopag Drugs Sales Market Share by Country (2021–2032)
Figure 22. North America Eltrombopag Drugs Revenue Market Share by Country (2021–2032)
Figure 23. United States Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Eltrombopag Drugs Sales Market Share by Country (2021–2032)
Figure 26. Europe Eltrombopag Drugs Revenue Market Share by Country (2021–2032)
Figure 27. Germany Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Eltrombopag Drugs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Eltrombopag Drugs Revenue Market Share by Region (2021–2032)
Figure 34. China Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Eltrombopag Drugs Sales Market Share by Country (2021–2032)
Figure 42. Latin America Eltrombopag Drugs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Eltrombopag Drugs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Eltrombopag Drugs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Eltrombopag Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Eltrombopag Drugs by Type (2021–2032)
Figure 53. Global Revenue Market Share of Eltrombopag Drugs by Type (2021–2032)
Figure 54. Global Eltrombopag Drugs Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Eltrombopag Drugs by Application (2021–2032)
Figure 56. Global Revenue Market Share of Eltrombopag Drugs by Application (2021–2032)
Figure 57. Global Eltrombopag Drugs Price (US$/Unit) by Application (2021–2032)
Figure 58. Eltrombopag Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
